Evidence map›Paper›PMID 40016203›Full record

ArticleNature communications2025

Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways.

David Aranda-García, Tomasz Maciej Stepniewski, Mariona Torrens-Fontanals, Adrian García-Recio, Marta Lopez-Balastegui, Brian Medel-Lacruz, Adrián Morales-Pastor, Alejandro Peralta-García, Miguel Dieguez-Eceolaza, David Sotillo-Nuñez and 33 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. The GPCRDiabetologia · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

David Aranda-GarcíaDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Tomasz Maciej StepniewskiResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Mariona Torrens-FontanalsDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0000-0001-6233-8945
Adrian García-RecioResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.ORCID http://orcid.org/0000-0002-7143-9075
Marta Lopez-BalasteguiDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Brian Medel-LacruzDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2831-7731
Adrián Morales-PastorDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Alejandro Peralta-GarcíaDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Miguel Dieguez-EceolazaDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0009-0008-9169-6416
David Sotillo-NuñezDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0009-0006-6414-8970
Tianyi DingSchool of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, Northern Ireland, UK.ORCID http://orcid.org/0000-0002-1989-3705
Matthäus DrabekDepartment of Pharmaceutical Chemistry, University of Marburg, Marburg, Germany.
Célien JacquemardLaboratoire d'Innovation Thérapeutique, University of Strasbourg, Strasbourg, France.ORCID http://orcid.org/0000-0002-9633-3429
Jakub JakowieckiFaculty of Chemistry, University of Warsaw, Warsaw, Poland.
Willem JespersDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-4951-9220
Mireia Jiménez-RosésCentre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Birmingham and Nottingham, Midlands, UK.ORCID http://orcid.org/0000-0002-4049-8670
Víctor Jun-Yu-LimDepartment of Pharmaceutical Chemistry, University of Marburg, Marburg, Germany.
Alessandro NicoliLeibniz Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0001-6177-9749
Urszula OrzelFaculty of Chemistry, University of Warsaw, Warsaw, Poland.
Aida ShahrakiDepartment of Pharmaceutical Chemistry, University of Marburg, Marburg, Germany.
Johanna K S TiemannMedizinische Fakultät, Institut für Medizinische Physik und Biophysik, Universität Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0001-7551-6245
Vicente Ledesma-MartinDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Francho Nerín-FonzDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0000-0002-5548-7608
Sergio Suárez-DouDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0000-0002-7929-9468
Oriol CanalDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.ORCID http://orcid.org/0000-0001-6292-5947
Gáspár Pándy-SzekeresDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Jiafei MaoBeijing National Laboratory for Molecular Sciences (BNLMS) and Center for Physicochemical Analysis and Measurement, Institute of Chemistry Chinese Academy of Science (ICCAS), Beijing, China.
David E GloriamDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-4299-7561
Esther KellenbergerLaboratoire d'Innovation Thérapeutique, University of Strasbourg, Strasbourg, France.ORCID http://orcid.org/0000-0002-9320-4840
Dorota LatekFaculty of Chemistry, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-0429-0637
Ramon Guixà-GonzálezDepartment of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.ORCID http://orcid.org/0000-0003-0397-9800
Hugo Gutiérrez-de-TeránDepartment of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-0459-3491
Irina G TikhonovaSchool of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, Northern Ireland, UK.ORCID http://orcid.org/0000-0002-6228-9431
Peter W HildebrandInstitute of Medical Physics and Biophysics, Medical University Leipzig, Leipzig, Sachsen, Germany.ORCID http://orcid.org/0000-0003-0063-1104
Marta FilizolaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-4382-8276
M Madan BabuDepartment of Structural Biology and Center of Excellence for Data Driven Discovery, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-0556-6196
Antonella Di PizioLeibniz Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-8520-5165
Slawomir FilipekFaculty of Chemistry, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0003-3147-3858
Peter KolbDepartment of Pharmaceutical Chemistry, University of Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0003-4089-614X
Arnau CordomiDepartment of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Spain.ORCID http://orcid.org/0000-0002-5793-2947
Toni GiorginoInstitute of Biophysics (IBF-CNR), National Research Council of Italy, Milano, Italy.ORCID http://orcid.org/0000-0001-6449-0596
Maria Marti-SolanoDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-0373-8927
Jana SelentDepartment of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain. jana.selent@upf.edu.ORCID http://orcid.org/0000-0002-1844-4449

Funding

COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
NIH HHS S10 OD030463
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) constitute a functionally diverse protein family and are targets for a broad spectrum of pharmaceuticals. Technological progress in X-ray crystallography and cryogenic electron microscopy has enabled extensive, high-resolution structural characterisation of GPCRs in different conformational states. However, as highly dynamic events underlie GPCR signalling, a complete understanding of GPCR functionality requires insights into their conformational dynamics. Here, we present a large dataset of molecular dynamics simulations covering 60% of currently available GPCR structures. Our analysis reveals extensive local "breathing" motions of the receptor on a nano- to microsecond timescale and provides access to numerous previously unexplored receptor conformational states. Furthermore, we reveal that receptor flexibility impacts the shape of allosteric drug binding sites, which frequently adopt partially or completely closed states in the absence of a molecular modulator. We demonstrate that exploring membrane lipid dynamics and their interaction with GPCRs is an efficient approach to expose such hidden allosteric sites and even lateral ligand entrance gateways. The obtained insights and generated dataset on conformations, allosteric sites and lateral entrance gates in GPCRs allows us to better understand the functionality of these receptors and opens new therapeutic avenues for drug-targeting strategies.

Indexed as

Allosteric SiteMolecular Dynamics SimulationReceptors, G-Protein-CoupledAllosteric RegulationBinding SitesCrystallography, X-RayHumansLigandsProtein BindingProtein ConformationLigandsReceptors, G-Protein-Coupled

Identifiers

PMID40016203
PMCPMC11868581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.